On Nov. 2, 2021, Lonza announced two acquisitions that will expand its exosomes development and manufacturing capabilities. The company will acquire the exosomes service unit from Exosomics, an extracellular vesicles biotech company, and a US-based exosomes manufacturing facility from Codiak BioSciences, a clinical-stage biopharmaceutical company specializing in exosome-based therapeutics. Source: Pharmtech 3/11/2021